Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 30199

1.

PEGylated liposomes for topical vaginal therapy improve delivery of interferon alpha.

Wenche Jøraholmen M, Basnet P, Acharya G, Škalko-Basnet N.

Eur J Pharm Biopharm. 2017 Jan 10. pii: S0939-6411(16)30434-9. doi: 10.1016/j.ejpb.2016.12.029. [Epub ahead of print]

PMID:
28087379
2.

Negative immune factors might predominate local tumor immune status and promote carcinogenesis in cervical carcinoma.

Zhao M, Li Y, Wei X, Zhang Q, Jia H, Quan S, Cao D, Wang L, Yang T, Zhao J, Pei M, Tian S, Yu Y, Guo Y, Yang X.

Virol J. 2017 Jan 13;14(1):5. doi: 10.1186/s12985-016-0670-8.

3.

Intention of Mothers in Israel to Vaccinate their Sons against the Human Papilloma Virus.

Ben Natan M, Midlej K, Mitelman O, Vafiliev K.

J Pediatr Nurs. 2017 Jan 9. pii: S0882-5963(16)30232-9. doi: 10.1016/j.pedn.2017.01.001. [Epub ahead of print]

PMID:
28081933
4.

Knowledge, Behaviors, and Attitudes About Human Papilloma Virus Among Nursing Students in Izmir, Turkey.

Bal-Yılmaz H, Koniak-Griffin D.

J Cancer Educ. 2017 Jan 10. doi: 10.1007/s13187-017-1163-1. [Epub ahead of print]

PMID:
28074443
5.

Knowledge of Greek adolescents on human papilloma virus (HPV) and vaccination: A national epidemiologic study.

Vaidakis D, Moustaki I, Zervas I, Barbouni A, Merakou K, Chrysi MS, Creatsa G, Panoskaltsis T.

Medicine (Baltimore). 2017 Jan;96(1):e5287. doi: 10.1097/MD.0000000000005287.

6.

Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).

Garg MK, Zhao F, Sparano JA, Palefsky J, Whittington R, Mitchell EP, Mulcahy MF, Armstrong KI, Nabbout NH, Kalnicki S, El-Rayes BF, Onitilo AA, Moriarty DJ, Fitzgerald TJ, Benson AB 3rd.

J Clin Oncol. 2017 Jan 9:JCO2016691667. [Epub ahead of print]

PMID:
28068178
7.

Modeling the Mechanisms by Which HIV-Associated Immunosuppression Influences HPV Persistence at the Oral Mucosa.

Verma M, Erwin S, Abedi V, Hontecillas R, Hoops S, Leber A, Bassaganya-Riera J, Ciupe SM.

PLoS One. 2017 Jan 6;12(1):e0168133. doi: 10.1371/journal.pone.0168133.

8.

Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome) - An update.

Watad A, Quaresma M, Brown S, Cohen Tervaert JW, Rodríguez-Pint I, Cervera R, Perricone C, Shoenfeld Y.

Lupus. 2017 Jan 1:961203316686406. doi: 10.1177/0961203316686406. [Epub ahead of print]

PMID:
28059022
9.

Will they lead by example? Assessment of vaccination rates and attitudes to human papilloma virus in millennial medical students.

Afonso NM, Kavanagh MJ, Swanberg SM, Schulte JM, Wunderlich T, Lucia VC.

BMC Public Health. 2017 Jan 6;17(1):35. doi: 10.1186/s12889-016-3969-x.

10.

Human papilloma virus in oral cancer.

Kim SM.

J Korean Assoc Oral Maxillofac Surg. 2016 Dec;42(6):327-336. doi: 10.5125/jkaoms.2016.42.6.327. Review.

11.

Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx.

Zhang Y, Sturgis EM, Li Y, Wei Q, Huang Z, Li G.

Sci Rep. 2017 Jan 3;7:39765. doi: 10.1038/srep39765.

12.

Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Koh WJ, Greer BE, Abu-Rustum NR, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Valea FA, Wyse E, Yashar CM, McMillian N, Scavone J.

J Natl Compr Canc Netw. 2017 Jan;15(1):92-120.

PMID:
28040721
13.

The Low-Risk Papillomaviruses.

Egawa N, Doorbar J.

Virus Res. 2016 Dec 28. pii: S0168-1702(16)30714-6. doi: 10.1016/j.virusres.2016.12.017. [Epub ahead of print] Review.

PMID:
28040475
14.

Incidental finding of an extensive oropharyngeal mass in magnetic resonance imaging of a patient with temporomandibular disorder: A case report.

Omolehinwa TT, Mupparapu M, Akintoye SO.

Imaging Sci Dent. 2016 Dec;46(4):285-290. doi: 10.5624/isd.2016.46.4.285.

15.

Bilateral Plantar Verrucous Carcinoma.

Riccio C, King K, Elston JB, Harrington MA, Cruse CW.

Eplasty. 2016 Dec 7;16:ic46. No abstract available.

16.

Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase.

Vert A, Castro J, Ribó M, Benito A, Vilanova M.

Oncotarget. 2016 Dec 27. doi: 10.18632/oncotarget.14302. [Epub ahead of print]

17.

Recent Trends in Oral Cavity Cancer Research Support in the United States.

Fribley AM, Svider PF, Warner BM, Garshott DM, Raza SN, Kirkwood KL.

J Dent Res. 2017 Jan;96(1):17-22. doi: 10.1177/0022034516680556.

PMID:
28033064
18.

Elevated Expression of Ox2R in Cervical Cancers and Placentas of Uyghur Women in Xinjiang, China

Taximaimaiti R, Abuliken X, Maihemuti M, Abudujilile D, Abudulimu H.

Asian Pac J Cancer Prev. 2016 Nov 1;17(11):4959-4963.

19.

TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)?

Meulenaere A, Vermassen T, Aspeslagh S, Vandecasteele K, Rottey S, Ferdinande L.

Head Neck Pathol. 2016 Dec 28. doi: 10.1007/s12105-016-0776-8. [Epub ahead of print] Review.

PMID:
28032290
20.

Detection of human papilloma virus in potentially malignant and malignant lesions of the oral cavity and a study of associated risk factors.

Bijina BR, Ahmed J, Shenoy N, Ongole R, Shenoy S, Baliga S.

South Asian J Cancer. 2016 Oct-Dec;5(4):179-181. doi: 10.4103/2278-330X.195337.

Items per page

Supplemental Content

Loading ...
Support Center